A phase II study of carboplatin and weekly docetaxel in advanced non-small cell lung cancer

被引：0
|
作者：
Moore, T [1 ]
Patel, T [1 ]
Segal, M [1 ]
Thompson, J [1 ]
Zangmeister, J [1 ]
Larrimer, N [1 ]
Merriman, N [1 ]
Chidiac, T [1 ]
机构：
[1] Mid Ohio Oncol Hematol, Columbus, OH USA
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 50 条
  • [31] A phase II trial of biweekly docetaxel combined with carboplatin for patients with advanced non-small cell lung cancer
    Ishimoto, O
    Sugawara, S
    Inoue, A
    Ishida, T
    Koinumaru, S
    Hasegawa, Y
    Suzuki, T
    Miki, H
    Saijo, Y
    Nukiwa, T
    [J]. LUNG CANCER, 2005, 49 : S391 - S391
  • [32] Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
    Park, Se Hoon
    Hong, Junshik
    Kim, Young Saing
    Kim, Yujin
    Kyung, Sun Young
    An, Chang Hyeok
    Lee, Sang Pyo
    Park, Jeong Woong
    Jeong, Sung Hwan
    Park, Jinny
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    [J]. LUNG CANCER, 2008, 62 (01) : 72 - 77
  • [33] Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer
    Hillerdal, Gunnar
    Sederholm, Christer
    Andersson, Kerstin
    [J]. LUNG CANCER, 2011, 71 (02) : 178 - 181
  • [34] A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer
    Dragnev, Konstantin H.
    Whyman, Jeremy D.
    Hahn, Cynthia K.
    Kebbekus, Peter E.
    Kokko, Sarah F.
    Bhatt, Sunil M.
    Rigas, James R.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5531 - 5537
  • [35] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] A PHASE I/II STUDY OF BEXAROTENE WITH WEEKLY PACLITAXEL AND CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Whyman, Jeremy D.
    Kebbekus, Peter E.
    Fink, Sarah K.
    Rigas, James R.
    Dragnev, Konstantin H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S883 - S883
  • [37] Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer
    Niho, S
    Ohe, Y
    Kakinuma, R
    Kubota, K
    Matsumoto, T
    Ohmatsu, H
    Goto, K
    Nishiwaki, Y
    [J]. LUNG CANCER, 2002, 35 (02) : 209 - 214
  • [38] Carboplatin and vinorelbine in advanced non-small cell lung cancer: A phase I/II study
    Masters, G
    [J]. ONCOLOGIST, 2001, 6 : 12 - 15
  • [39] Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)
    Ozguroglu, Mustafa
    Evrensel, Turkkan
    Er, Ozlem
    Turna, Hande
    Yanmaz, Teoman
    Yildiz, Ozcan
    Mandel, Nil
    Serdengecti, Suheyla
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
  • [40] WEEKLY DOCETAXEL AND CARBOPLATIN WITH CONCURRENT RADIATION THERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Tanikawa, Y.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 123 - 123
12345